Works matching IS 11707690 AND DT 1999 AND VI 15 AND IP 5

Results: 14

Health Economics in HIV Disease: A Review of the European Literature.

Published in:

PharmacoEconomics, 1999, v. 15, n. 5, p. 1, doi. 10.2165/00019053-199915001-00001

By:

Youle, M.;
Trueman, P.;
Simpson, K.

Publication type:

Article

Lamivudine Reduces Healthcare Resource Use when Added to Zidovudine-Containing Regimens in Patients with HIV Infection.

Published in:

PharmacoEconomics, 1999, v. 15, n. 5, p. 13, doi. 10.2165/00019053-199915001-00002

By:

Lacey, L.;
Gill, M.J.

Publication type:

Article

A Prospective Cost-Consequence Analysis of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens for HIV Infection in the US.

Published in:

PharmacoEconomics, 1999, v. 15, n. 5, p. 23, doi. 10.2165/00019053-199915001-00003

By:

Lacey, L.;
Mauskopf, J.;
Lindrooth, R.;
Pham, S.;
Saag, M.;
Sawyer, W.

Publication type:

Article

A Prospective Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens in HIV Infection: European Perspective.

Published in:

PharmacoEconomics, 1999, v. 15, n. 5, p. 39, doi. 10.2165/00019053-199915001-00004

By:

Lacey, L.;
Youle, M.;
Trueman, P.;
Staszewski, S.;
Schrappe, M.;
Behrens, M.

Publication type:

Article

An Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Regimens in HIV Infection: Canadian Perspective.

Published in:

PharmacoEconomics, 1999, v. 15, n. 5, p. 55, doi. 10.2165/00019053-199915001-00005

By:

Lacey, L.;
Hopkinson, P.K.;
Montaner, J.;
Leblanc, F.;
Gill, M.J.

Publication type:

Article

Quality of Life and Treatment Satisfaction After the Addition of Lamivudine or Lamivudine plus Loviride to Zidovudine-Containing Regimens in Treatment-Experienced Patients with HIV Infection.

Published in:

PharmacoEconomics, 1999, v. 15, n. 5, p. 67, doi. 10.2165/00019053-199915001-00006

By:

Chatterton, M.L.;
Scott-Lennox, J.;
Wu, A.W.;
Scott, J.

Publication type:

Article

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies.

Published in:

1999

By:

Revicki, D.A.;
Frank, L.

Publication type:

journal article

Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies?

Published in:

1999

By:

Duerden, M.;
Walley, T.

Publication type:

journal article

Counting the costs of drug-related adverse events.

Published in:

1999

By:

White, T.J.;
Arakelian, A.;
Rho, J.P.

Publication type:

journal article

The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.

Published in:

1999

By:

Glennie, J.L.;
Torrance, G.W.;
Baladi, J.F.;
Berka, C.;
Hubbard, E.;
Menon, D.;
Otten, N.;
Riviére, M.;
Rivière, M

Publication type:

journal article

Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.

Published in:

1999

By:

Hamilton, S.H.;
Revicki, D.A.;
Edgell, E.T.;
Genduso, L.A.;
Tollefson, G.

Publication type:

journal article

Reconciling decision models with the real world. An application to anaemia of renal failure.

Published in:

1999

By:

Shih, Y-C.T.;
Kauf, T.L.;
Shih, Y C

Publication type:

journal article

Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.

Published in:

1999

By:

Griffiths, R.I.;
Sullivan, E.M.;
Frank, R.G.;
Strauss, M.J.;
Herbert, R.J.;
Clouse, J.;
Goldman, H.H.

Publication type:

journal article

Direct costs of hip fractures in patients over 60 years of age in Belgium.

Published in:

1999

By:

Reginster, J-Y.;
Gillet, P.;
Sedrine, W.B.;
Brands, G.;
Ethgen, O.;
defroidmont, C.;
Gosset, C.;
Ben Sedrine, W;
de Froidmont, C

Publication type:

journal article